# A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction

> **NCT05806138** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 21 (actual)

## Conditions studied

- Breast Cancer
- Cardiac Dysfunction

## Interventions

- **DRUG:** Vericiguat
- **OTHER:** Optimal medical therapy

## Key facts

- **NCT ID:** NCT05806138
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-07-17
- **Primary completion:** 2028-07-17
- **Final completion:** 2028-07-17
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2025-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05806138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05806138, "A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05806138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*